SEC 13F Intelligence

Altium Capital Management LLC / AXSM

Altium Capital Management LLC’s Axsome Therapeutics Inc. Position

Does Altium Capital Management LLC own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 58.0K shares worth $5M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2024
Shares
58.0K
% of Portfolio
+1.53%
Quarters Held
6
position exited

Position History AXSM

Reported value by quarter
Q2 ’23: $3MQ2 ’23Q3 ’23: $6MQ3 ’23Q4 ’23: $11MQ4 ’23Q1 ’24: $11MQ1 ’24Q2 ’24: $4MQ2 ’24Q3 ’24: $5MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202458.0K$5M+1.53%
Q2 202450.0K$4M+1.64%
Q1 2024138.0K$11M+4.36%
Q4 2023138.0K$11M+7.46%
Q3 202392.0K$6M+3.35%
Q2 202340.0K$3M+2.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of AXSM.